Literature DB >> 1831491

Genetic dissection of T cell receptor V beta gene requirements for spontaneous murine diabetes.

J A Shizuru1, C Taylor-Edwards, A Livingstone, C G Fathman.   

Abstract

It has been demonstrated, in certain autoimmune disease models, that pathogenic T cells express antigen receptors of limited diversity. It has been suggested that the T cells responsible for the pathogenesis of type I diabetes mellitus might similarly demonstrate restricted T cell receptor (TCR) usage. Recently, attempts have been made to identify the V beta subset(s) that initiates and/or perpetuates the antiislet response in a mouse model of spontaneous autoimmune diabetes (non-obese diabetic [NOD] mice). In studies reported here, we have bred NOD mice to a mouse strain that congenitally lacks approximately one-half of the conventional TCR V beta alleles. Included in this deletion are TCR V beta gene products previously implicated as being involved in the pathogenesis of NOD disease. By studying second backcross-intercross animals, we were able to demonstrate that this deletion of TCR V beta gene segments did not prevent the development of insulitis or diabetes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831491      PMCID: PMC2118938          DOI: 10.1084/jem.174.3.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

Review 1.  T cell receptors in murine autoimmune diseases.

Authors:  H Acha-Orbea; L Steinman; H O McDevitt
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion.

Authors:  F W Symington; J Sprent
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

4.  The use of the avidin-biotin complex as a tool in molecular biology.

Authors:  E A Bayer; M Wilchek
Journal:  Methods Biochem Anal       Date:  1980

Review 5.  Immunology of insulin-dependent diabetes mellitus.

Authors:  A A Rossini; J P Mordes; A A Like
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

6.  Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression.

Authors:  A Livingstone; C T Edwards; J A Shizuru; C G Fathman
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

7.  Expression of a murine polyclonal T cell receptor marker correlates with the use of specific members of the V beta 8 gene segment subfamily.

Authors:  M A Behlke; T J Henkel; S J Anderson; N C Lan; L Hood; V L Braciale; T J Braciale; D Y Loh
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

8.  The T cell receptor repertoire influences V beta element usage in response to myoglobin.

Authors:  G Ruberti; A Gaur; C G Fathman; A M Livingstone
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

9.  Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis.

Authors:  S S Zamvil; D J Mitchell; N E Lee; A C Moore; M K Waldor; K Sakai; J B Rothbard; H O McDevitt; L Steinman; H Acha-Orbea
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.

Authors:  L S Wicker; B J Miller; L Z Coker; S E McNally; S Scott; Y Mullen; M C Appel
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  13 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses.

Authors:  William M Ridgway
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

Review 3.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 4.  The immunologic insult in type 1 diabetes.

Authors:  M C Honeyman; L C Harrison
Journal:  Springer Semin Immunopathol       Date:  1993

5.  A comparative study of T-cell receptor V beta usage in non-obese diabetic (NOD) and I-E transgenic NOD mice.

Authors:  N M Parish; H Acha-Orbea; E Simpson; S X Qin; T Lund; A Cooke
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

6.  Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.

Authors:  A Hänninen; S Jalkanen; M Salmi; S Toikkanen; G Nikolakaros; O Simell
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 7.  Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?

Authors:  E J Rashba; E P Reich; C A Janeway; R S Sherwin
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

8.  Reactive oxygen intermediates in autoimmune islet cell destruction of the NOD mouse induced by peritoneal exudate cells (rich in macrophages) but not T cells.

Authors:  F Horio; M Fukuda; H Katoh; M Petruzzelli; N Yano; C Rittershaus; S Bonner-Weir; M Hattori
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

9.  Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.

Authors:  T Taki; K Yokono; K Amano; N Hatamori; Y Hirao; Y Tominaga; S Maeda; M Kasuga
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

10.  Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: identification of a susceptibility haplotype in the Tcrb-V locus.

Authors:  John P Mordes; Laura Cort; Elaine Norowski; Jean Leif; Jessica M Fuller; Ake Lernmark; Dale L Greiner; Elizabeth P Blankenhorn
Journal:  Mamm Genome       Date:  2009-02-10       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.